Preparation and characterization of silybin-loaded nanostructured lipid carriers

被引:99
作者
Jia, Le-Jiao [1 ]
Zhang, Dian-Rui [1 ]
Li, Zhen-Yu [2 ]
Feng, Fei-Fei [1 ]
Wang, Yan-Cai [1 ]
Dai, Weil-Ting [1 ]
Duan, Cun-Xian [1 ]
Zhang, Qiang [3 ]
机构
[1] Shandong Univ, Coll Pharm, Dept Pharmaceut, Jinan 250012, Peoples R China
[2] Shandong Univ, Coll Pharm, Dept Med Chem, Jinan 250012, Peoples R China
[3] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100083, Peoples R China
关键词
Nanostructured lipid carriers; Silybin; differential scanning calorimetry; X-ray diffraction; in vitro release; NANOPARTICLES SLN; ELECTRON-MICROSCOPY; BODY DISTRIBUTION; MILK THISTLE; SPECTROSCOPY; DELIVERY; MARIANUM; SYSTEM; NLC;
D O I
10.3109/10717540903431586
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nanostructured lipid carriers (NLC) are a new generation of lipid nanoparticles, which are produced by controlled mixing of solid lipids with spatially incompatible liquid lipids leading to special nanostructures with improved drug incorporation and release properties. In this study, silybin-loaded nanostructured lipid carriers with various liquid lipid content were successfully prepared by the method of emulsion evaporation at a high temperature and solidification at a low temperature. The size and morphology of nanoparticles were significantly influenced by the liquid lipid content. As the liquid lipid content increased to 20 wt%, the obtained particles showed distinguished smaller size. Compared with solid lipid nanoparticles (SLN), NLC presented improved drug loading capacity which increased with increasing the liquid lipid content. The differential scanning calorimetry (DSC) and X-ray diffraction (XRD) analysis indicated that the incorporation of liquid lipids could interfere with the crystallization of solid lipids. The drug in vitro release behavior from NLC displayed a biphasic drug release pattern with burst release at the initial stage and prolonged release afterwards, and the successful controlled release rate can be achieved by controlling the liquid lipid content.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 24 条
[1]   Interaction of drug molecules with carrier systems as studied by parelectric spectroscopy and electron spin resonance [J].
Braem, C. ;
Blaschke, T. ;
Panek-Minkin, G. ;
Herrmann, W. ;
Schlupp, P. ;
Paepenmueller, T. ;
Mueller-Goyman, C. ;
Mehnert, W. ;
Bittl, R. ;
Schaefer-Korting, M. ;
Kramer, K. D. .
JOURNAL OF CONTROLLED RELEASE, 2007, 119 (01) :128-135
[2]   Milk thistle (Silybum marianum) for the therapy of liver disease [J].
Flora, K ;
Hahn, M ;
Rosen, H ;
Benner, K .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (02) :139-143
[3]   The production and characteristics of solid lipid nanoparticles (SLNs) [J].
Hou, DZ ;
Xie, CS ;
Huang, KJ ;
Zhu, CH .
BIOMATERIALS, 2003, 24 (10) :1781-1785
[4]   Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system [J].
Hu, FQ ;
Jiang, SP ;
Du, YZ ;
Yuan, H ;
Ye, YQ ;
Zeng, S .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2005, 45 (3-4) :167-173
[5]  
Jenning V, 2001, J MICROENCAPSUL, V18, P149
[6]   Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids [J].
Jenning, V ;
Thünemann, AF ;
Gohla, SH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 199 (02) :167-177
[7]   Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy [J].
Jores, K ;
Mehnert, W ;
Drechsler, M ;
Bunjes, H ;
Johann, C ;
Mäder, K .
JOURNAL OF CONTROLLED RELEASE, 2004, 95 (02) :217-227
[8]  
Liu XL, 2009, J MICROENCAPSUL, V26, P180, DOI [10.1080/02652040802211741, 10.1080/02652040802211741 ]
[9]   Solid lipid nanoparticles -: Production, characterization and applications [J].
Mehnert, W ;
Mäder, K .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (2-3) :165-196
[10]   Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles [J].
Muller, RH ;
Maassen, S ;
Weyhers, H ;
Specht, F ;
Lucks, JS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 138 (01) :85-94